This announcement is a separate document:
國藥控股：公告 國藥一致截至2023 年9 月30 日止第三季度之 主要未經審核會計數據和財務指標
SINOPHARM: ANNOUNCEMENT PRINCIPAL UNAUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM ACCORD FOR THE THIRD QUARTER ENDED 30 SEPTEMBER 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.